SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002382
Filing Date
2019-04-18
Accepted
2019-04-18 16:32:32
Documents
10
Period of Report
2019-05-29
Effectiveness Date
2019-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238438zdef14a.htm DEF 14A 556464
2 G560220.JPG g560220.jpg GRAPHIC 25227
3 G785187.JPG g785187.jpg GRAPHIC 4239
4 G140562.JPG g140562.jpg GRAPHIC 4845
5 G25272BGI001.JPG g25272bgi001.jpg GRAPHIC 97106
6 G25272BGI002.JPG g25272bgi002.jpg GRAPHIC 125590
7 G25272BII001.JPG g25272bii001.jpg GRAPHIC 84085
8 G25272BII002.JPG g25272bii002.jpg GRAPHIC 111335
9 G25272BII003.JPG g25272bii003.jpg GRAPHIC 36839
10 G25272BII004.GIF g25272bii004.gif GRAPHIC 3674
  Complete submission text file 0001047469-19-002382.txt   1237576
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35986 | Film No.: 19756291
SIC: 2834 Pharmaceutical Preparations